SOM 230 and Everolimus in Combination for the Treatment of Prostate Cancer
 
Sponsors and Collaborators
Thomas Jefferson University
Novartis Pharmaceuticals
 
Contact
Jianqing Lin, MD
215-955-8874
 
Clinical Research Management Office
215-955-1661
 
Investigator
Jianqing Lin, MD
Thomas Jefferson University
 
ClinicalTrials.gov Identifier